Venue
Aloft Boston Seaport District Hotel, 401-403 D Street, Boston, Massachusetts, 02210
The AI Driven Drug Discovery Team invites you to join us at the Aloft Boston Seaport District Hotel, November 12-14.
Robert Goodnow
Head of Drug Discovery SciencesTakedaPeter Clark
VP Computational Drug DesignNovo NordiskJacob Berlin
CEOTerray TherapeuticsMark Adams
Venture Capital PartnerTwo Bear CapitalLu Zhang
Founder & Managing PartnerFusion FundZachary Webel
Data Scientist and Applied MathematicianFDALena Dolgikh
Head of Computational ChemistryMonte Rosa TherapeuticsEd Addison
Executive Chairman & Acting CEOCLOUD PHARMACEUTICALSZhiyong (Sean) Xie
VP & Head of AI & Data ScienceXellarbioArvind Rao
Associate Professor Computational Medicine & BioinformaticsUniversity of MichiganMonica Wang
Head of Biologics & Novel Modality Discovery Capabilities & Products, Scientific InformaticsTakedaSimon Beaulah
SVP Precision Drug RepositioningPRECISIONLIFEPetrina Kamya
Global Head of AI Platforms, VP Insilico Medicine PresidentInsilico Medicine Canada Inc.Rohit Arora
Innovation LeadNovo NordiskAri Allyn-Feuer
Director AI ProductGSKKaren Akinsanya
President R&DSchrodingerSriram Chandrasekaran
Associate Professor, Biomedical EngineeringUniversity of MichiganMani Foroohar
Senior Managing Director Biotechnology AnalystLeerinkNevin Gerek Ince
Director Data & Solutions EngineeringNovo NordiskZoran Krunic
Principal Product ManagerAmgenSince joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and clinical datasets. His pioneering work in the Quantum Machine Learning space, in collaboration with IBM's Quantum team, has been instrumental in integrating machine learning with quantum computing through IBM’s Qiskit platform.
Prior to his tenure at Amgen, Zoran developed Machine Learning algorithms at Optum to predict hardware and software failures within complex enterprise architectures. He has a strong background in data engineering and systems development, having contributed significantly to large-scale projects at renowned organizations such as Capital Group and ARCO Petroleum.
In his current full and part-time endeavors, Zoran is leading the efforts in embracing generative AI technologies, with a particular focus on OpenAI's GPT and Anthropic's Claude-2 models. His work is focused on prompt engineering and its application to code generation, advanced document analysis, and process management, with a commitment to ethical AI practices and data privacy.
A recognized voice in quantum computing circles, Zoran is a regular presenter at industry conferences and has served on numerous panels discussing the integration of quantum computing and generative AI within the Health Sciences sector.
With a Master of Science in Electrical Engineering & Computer Science, Zoran continues to explore and contribute to the evolving relationship between quantum computing and artificial intelligence, fostering groundbreaking advancements in healthcare technology.
Hayley Donnella
Director of Computational OncologyRecursionLauris Kemp
Partner & Patent AttorneyHGFDaniyal Hussain
Executive Director of Technology Business DevelopmentGSKYu Qiu
Head of AI Innovation - Antibody Digital Biologics PlatformSanofiSerhat Tetikol
Associate DirectorBristol Myers SquibbYang-ming Zhu
SVP Head of Engineering (AI & ML)SuperluminalChirag Sacher
Director Portfolio InnovationNovartisJulian Hess
Computational ScientistBroad Institute of MIT & HarvardElena Diaz Cecilia
Senior Director, External InnovationJanssen R&DPeter McLean
Director Data ScienceRecursionClaire Leurent
Managing DirectorAbbvie VenturesAiden Acever
VPInsight PartnersXia Ning
ProfessorOhio State UniversityJackie Hunter
CEOOI Pharma PartnersEthan Pickering
Head of Data Science & Machine Learning ResearchBayerSoujanya Bhumkar
Co-FounderGen1e LifesciencesAshwini Ghogare
Head of AI & Automation in Drug DiscoveryMilliporeSigmaCharles O’Donnell
Vice President Head of Computational Genomics & Data SciencesOmega TherapeuticsBrendan Frey
Founder & Chief Innovation OfficerDeep GenomicsDuncan Ng
Vice President, Solutions EngineeringVultrDuncan Ng is Vultr's Vice President, Solutions Engineering. Duncan leads Vultr's Pre-Sales, Technical Account Management, and Partner Engineering organization. In this role he spearheads Vultr's global Technical Sales strategy and execution for Vultr customers through their entire customer journey. Duncan has decades of experience in delivering hyperscale offerings across domains including high performance computing, network engineering, data center infrastructure, and white & gray-space fit out. Previously Duncan held roles at Earthlink, Eaton, and BPR Advisory.